Sponsor:
Cynata Therapeutics Limited
Code:
NCT05643638
Conditions
Graft Versus Host Disease, Acute
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CYP-001: Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSCs)
Placebo
Corticosteroids
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-18. This information was provided to ClinicalTrials.gov by Cynata Therapeutics Limited on 2025-01-24.